Pivotal trials of the robot are expected to get underway in 2023 in the hope of bringing the robot to market in Europe in 2024, said Vitestro in a statement. Other groups are also developing blood ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.